Background: Chronic arsenic exposure is associated with increased risk for arsenical skin lesions, cancer, and other adverse health outcomes. One potential mechanism of arsenic toxicity is telomere dysfunction. However, prior epidemiological studies of arsenic exposure, telomere length (TL), and skin lesion are small and crosssectional. We investigated the associations between arsenic exposure and TL and between baseline TL and incident skin lesion risk among individuals participating in the Health Effects of Arsenic Longitudinal Study in Bangladesh (2000Bangladesh ( -2009. Methods: Quantitative PCR was used to measure the average TL of peripheral blood DNA collected at baseline. The association between baseline arsenic exposure (well water and urine) and TL was estimated in a randomlyselected subcohort (n = 1469). A nested case-control study (466 cases and 464 age-and sex-matched controls) was used to estimate the association between baseline TL and incident skin lesion risk (diagnosed < 8 years after baseline). Results: No association was observed between arsenic exposure (water or urine) and TL. Among incident skin lesion cases and matched controls, we observed higher skin lesion risk among individuals with shorter TL (P trend = 1.5 × 10 −5 ) with odds ratios of 2.60, 1.59, and 1.10 for the first (shortest), second, and third TL quartiles compared to the fourth (longest). Conclusions: Arsenic exposure was not associated with TL among Bangladeshi adults, suggesting that leukocyte TL may not reflect a primary mode of action for arsenic's toxicity. However, short TL was associated with increased skin lesion risk, and may be a biomarker of arsenic susceptibility modifying arsenic's effect on skin lesion risk.
Introduction
More than 100 million people worldwide experience chronic arsenic exposure through naturally contaminated drinking water (World Health Organization, 2001) , including approximately 20-45 million in Bangladesh (Flanagan et al., 2012) . Arsenic exposure has been reported to increase the risk of various adverse health outcomes including mortality (Sohel et al., 2009) , neurological conditions (Vahidnia et al., 2007) , cardiovascular diseases (States et al., 2009) , as well as malignancies such as cancers of the skin, bladder, kidney, liver, and lung (Celik et al., 2008; Hopenhayn-Rich et al., 1998; Liu and Waalkes, 2008; Mink et al., 2008; Yu et al., 2006 ). An early and common sign of arsenic toxicity is the appearance of skin lesions, which can reflect susceptibility to arsenic-related diseases, including cancers (Yu et al., 2006; Cuzick et al., 1982 Cuzick et al., , 1992 Hsu et al., 2013; Arsenic in Drinking Water, 2001 ).
The mechanism of arsenic's toxicity and carcinogenicity may be related in part to telomere length and dysfunction. Telomeres are the repeating six-nucleotide sequence binding protein complexes at the end of human chromosomes that protect DNA ends from damage. The telomerase enzyme elongates telomeres in stem and progenitor cells (Shawi and Autexier, 2008) . Telomere length (TL) shortening occurs with cell division and has been investigated as a biomarker of aging and susceptibility for age-related health conditions, including cardiovascular diseases, neurocognitive diseases, cancers, and overall mortality (Cawthon et al., 2003; Martin-Ruiz et al., 2006; Sanders and Newman, 2013; Serrano and Andrés, 2004; Willeit et al., 2010) , all of which have also been linked with chronic arsenic exposure. In vitro studies of human cord blood cells and human cell lines have shown that arsenic exposure can both increase and decrease TL and telomerase activity depending on dose (Ferrario et al., 2009; Zhang et al., 2003) . Acceleration of TL shortening has been attributed in part to oxidative stress and inflammation (Jenny, 2012; O'Donovan et al., 2011; Von Zglinicki, 2002) , two processes that are also potential causes of arsenic toxicity Kitchin, 2001; Liu et al., 2003) .
Recent epidemiologic studies linked arsenic exposure to longer TL in peripheral blood and saliva (Chatterjee et al., 2015; Fillman et al., 2016; Gao et al., 2015; Li et al., 2012; Ameer et al., 2016) and altered peripheral blood expression of genes involved in telomere maintenance (Gao et al., 2015; Li et al., 2012; Mo et al., 2009 ). However, the few published studies of the association between arsenic exposure and TL tend to be small, and only one study to date has investigated the association between TL and arsenical skin lesions-a cross-sectional study that found longer TL in skin lesion subjects (Chatterjee et al., 2015) . The goal of this paper was to characterize the role of TL in the arsenicskin lesion association by answering two questions: 1) whether arsenic exposure is associated with TL; and 2) whether TL is associated with skin lesion risk. Addressing these questions will allow us to determine whether TL is a mediator or modifier of the association between arsenic and skin lesion. In animal models, shorter telomere length has been associated with skin lesions including ulcerations with epidermal hyperplasia and hyperkeratosis (Rudolph et al., 1999; Varela et al., 2016) . UV radiation-induced short TL has previously been linked to actinic keratosis in human subjects, suggesting that TL may play a role in the biology of skin lesions independent of any arsenic exposure (Ikeda et al., 2014) . Furthermore, given that age is a risk factor for skin lesion (Ahsan et al., 2006) , and TL is related to multiple diseases of aging (Haycock et al., 2017) , we additionally hypothesize that TL may independently affect skin lesion risk. Prospective studies assessing the association between baseline TL and risk of subsequent arsenic-related skin lesions are needed to establish the temporal relationship between TL and skin lesion risk, allowing for the evaluation of TL as a biomarker for susceptibility to arsenic-related skin lesions in exposed populations.
In this study, we assessed the associations between arsenic exposure and TL and between baseline TL and subsequent skin lesions among Bangladeshi individuals with a wide range of arsenic exposure through drinking water.
Methods

Study participants
The Health Effects of Arsenic Longitudinal Study (HEALS) in Araihazar, Bangladesh is a prospective cohort study designed to assess the effects of exposure to arsenic through drinking water on health. Details of the participant selection, study design, and study methods have been described previously (Ahsan et al., 2005) . In brief, 11,746 male and female participants were recruited between 2000 and 2002 in Araihazar, Bangladesh. The study location is in a rural area with relatively homogeneous sociocultural characteristics. The cohort has been expanded in subsequent years but the current study is conducted among this original cohort. Demographic and lifestyle data as well as blood (from which TL is measured) and urine samples were collected at baseline. In-person visits were conducted every two years following the baseline visit and each visit included a physical examination and collection of urine. All subjects in the study received basic medical care through the study clinic. Informed consent was obtained from all study participants, and the study protocol was approved by the Institutional Review Boards of the University of Chicago, Columbia University, and the ethical committee of the Bangladesh Medical Research Council.
Skin lesion status
During the baseline interview as well as three biennial follow-ups, participants were examined by trained physicians for the presence of arsenical skin lesions according to a structured protocol. The physicians, who were blinded to the participants' arsenic exposure status, recorded the presence of melanosis (hyperpigmentation), leucomelanosis (hypopigmentation), or keratosis (thickening of the skin on palms and soles). For this study, skin lesion status was defined as the presence or absence of any type of the aforementioned skin lesions. Over the course of the three biennial follow-ups after baseline, 866 individuals developed incident skin lesions among the 10,182 skin lesion-free individuals at baseline .
Selection of the subcohort
A random subset of the baseline HEALS cohort was selected (n = 1469), including participants with prevalent (i.e. pre-existing) skin lesions at baseline (Ahsan et al., 2006; Argos et al., 2011) . Although we have arsenic exposure measurements for a larger sample of subjects from the Bangladesh Vitamin E and Selenium Trial (BEST) (n = 1825) and the expansion of the HEALS cohort (ACE) (n = 1047), only HEALS subjects were included in the analysis in order to avoid any issues of exposure misclassification. HEALS subjects' baseline exposure reflects historical exposure as participants were not aware of the arsenic exposure status at baseline (Chen et al., 2007) , whereas many BEST and ACE participants may have been aware of their exposure status at baseline and have had the opportunity to change their exposure in response to arsenic mitigation efforts. We chose to conduct this analysis in a randomly-selected subcohort rather than in a selected group of skinlesion cases and/or controls in order to avoid collider bias (Cole et al., 2010) . Collider bias is a form of selection bias in which a spurious association is induced between two variables when the analysis is conditioned on a common outcome (e.g. conditioning on skin lesion status, a potential common effect of both arsenic exposure and TL). TL measures were not obtained for the full cohort due to limited resources.
Nested case-control study selection
To assess associations between TL and skin lesion status, we conducted a nested case-control study of 516 individuals with incident skin lesions who were frequency matched by sex and 5-year age intervals with 516 individuals who remained skin lesion-free during the study. Subjects selected for the nested case-control study partially overlap with the random subcohort, but also include additional individuals from the parent HEALS study. We chose to perform age-and sexmatching for this analysis because age and sex are well-described correlates of TL (Sanders and Newman, 2013) , which may confound the association between TL and skin lesion status. Among the subjects selected for the nested case-control study, samples for 92 subjects were excluded from the analysis due to TL assay quality control measures as detailed below, resulting in 466 cases and 464 controls. Fig. 1 shows a flowchart of the selection of participants for the nested case-control study. Characteristics of subjects excluded due to insufficient DNA and TL assay quality control are shown in Supplementary Tables 1 and 2, respectively.
Exposure assessment
Ascertainment of arsenic exposure through well water has previously been described (Ahsan et al., 2005; Cheng et al., 2004; Nixon et al., 1991) . In brief, arsenic concentrations of water samples were measured from the wells identified by participants as their primary source of drinking water. Urinary total arsenic concentration and urinary creatinine were measured by methods previously described (Nixon et al., 1991; Heinegård and Tiderström, 1973) . A creatinineadjusted urinary total arsenic concentration, expressed as μg/g of creatinine, was calculated by dividing urinary total arsenic by creatinine . Daily arsenic intake (μg/day) was calculated by multiplying the primary well water arsenic concentration (μg/ L) by the self-reported daily water volume consumed from that well (L/ day) with secondary well information also incorporated in the calculation . Water arsenic exposure was modeled as four levels with the first two cut points defined according to the WHO's guideline for arsenic in drinking water (≤ 10 µg/L) and Bangladesh's national standard for arsenic in drinking water (≤ 50 µg/L) (corresponding approximately to the first and second quartiles). The third cut point was selected based on the upper third and fourth quartiles of water arsenic exposure. Creatinine-adjusted urinary arsenic concentration and daily arsenic intake were categorized by quartiles based on the distribution of each measure in the randomly-selected subcohort. Although arsenic exposure was assessed during follow-up visits, only the first baseline arsenic exposure was used for the association analyses in this study, representative of long-term arsenic exposure prior to arsenic mitigation efforts.
To further investigate the potential impact of arsenic exposure on TL, we assessed the association between TL and the single nucleotide polymorphism (SNP) rs9527 located in the 10q24.32 region. This variant was previously shown to be associated with percentages of arsenic metabolites monomethylarsonic acid and dimethylarsinic acid (Pierce et al., 2012 (Pierce et al., , 2013 and is likely to reflect the efficiency with which arsenic is cleared from the body and excreted in urine. Furthermore, rs9527 is associated with skin lesion risk through its interaction with arsenic exposure, indicating that genetic variation for arsenic metabolism can lead to differential "effective" arsenic exposure that affects arsenical skin lesion risk. Because this SNP represents genetic variation affecting the internal dose of arsenic, an analysis of its association with TL serves to confirm findings from the analysis of the association between arsenic exposure and TL. Genotyping data was obtained based on procedures previously described (Pierce et al., 2012 (Pierce et al., , 2013 ).
TL measurement
The method of TL measurement is similar to that of prior studies (Ehrlenbach et al., 2009; Cawthon, 2002) . In summary, quantitative polymerase chain reaction (PCR) was used to compare the abundance of the telomere repeat sequence to that of a single-copy gene, RPLP0, calculated as a ratio proportional to the average relative TL of a sample (T/S ratio). Inter-plate coefficient of variation of 37 randomly selected samples repeated on different days was 11.7% for one assessment of the reproducibility of the assay and 9.8% for a second assessment of reproducibility by measuring a reference sample across 31 plates. Additional details are provided in the Supplementary Materials, Supplementary Fig. 1 , and Supplementary Fig. 2 .
Covariates
The following variables measured at baseline were included as covariates in all analyses: age, sex, years of formal education (0, 1-5, 6-16 years), body mass index (BMI) (< 18.5, 18.5-24.9, > 25) , smoking (never, former, current), and TV and land ownership (measures of socioeconomic status). Covariates were selected a priori based on previously described correlates of arsenic exposure or TL (Sanders and Newman, 2013; Ahsan et al., 2006; Argos et al., 2010; Zhang et al., 2016) . TL quartiles were created based on the distribution of TL in the random subcohort.
Statistical analyses
We assessed the association between baseline arsenic exposure and TL in the randomly-selected subcohort using linear regression (n = 1469). To remove the variation in TL due to PCR plate position (accounting for 5-9% of the variation) or plate number (accounting for 13-25% of the variation), we first obtained the position-and plateadjusted residual TL measure for each plate design using a mixed-effects model with continuous TL as the outcome, position as a fixed effect, and plate as a random effect. The position-and plate-adjusted residual TL was then used as the outcome in minimally-adjusted linear regression models with TL as the outcome and arsenic exposure as the predictor, accounting for continuous age, sex, plate design type, and DNA extraction batch (a study design variable). Fully-adjusted models additionally included socioeconomic factors, smoking, and BMI as C. Zhang et al. Environmental Research 164 (2018) 346-355 covariates. Analyses were repeated using water arsenic, urinary arsenic, and daily arsenic dose (modeled as quartiles) as the arsenic exposure measure. P-trend was obtained by regressing TL on an ordinal coding of arsenic exposure. We also modeled arsenic exposure as a log-transformed continuous measure, compared the TL of subjects with the top decile of arsenic exposure to those with the bottom decile exposure, and compared the TL of subjects with the top decile of arsenic exposure to all other subjects with lower arsenic exposure for all three arsenic measures.
In the analysis of the arsenic metabolism SNP and TL, the association with rs9527 (coded as 0, 1 or 2 minor alleles) was performed in a sample of 5019 individuals with both SNP and TL data. This SNP-TL analysis was performed in a combined dataset of HEALS, BEST, and ACE. Although BEST and ACE differ from HEALS with respect to historic arsenic exposure, these samples were being analyzed for genetic variation in arsenic metabolism, which is randomly assigned at birth and does not vary over time or exposure. Therefore, we were able to leverage the larger sample size of all genotyped subjects with measured TL.
Next, we calculated the odds ratios (ORs) for the risk of skin lesions by quartile TL (and repeated with continuous TL) using conditional logistic regression accounting for case-control matching based on sexand age-defined strata (i.e., n to n matching). We again adjusted for plate position, plate number, and DNA extraction batch in minimallyadjusted conditional logistic regression models and included socioeconomic factors, smoking, BMI, and baseline arsenic exposure as covariates in fully-adjusted models. The analyses of the association between arsenic and TL and between TL and skin lesion were repeated after stratifying by sex and median age of skin lesion cases (< = 45, > 45), and tests of multiplicative interaction were performed by evaluating the Wald statistic for the cross-product interaction term from the regression model. We also investigated whether TL was an effect modifier of the association between arsenic and skin lesion with tests of multiplicative interaction assessing the P value of the cross-product term of the ordinal exposure variable (arsenic quartiles) and the ordinal effect modifier (TL quartiles) in the conditional logistic regression. The relative excess risk due to interaction (RERI) measure of additive interaction was calculated for each interaction assessed (Knol et al., 2007) . We chose to investigate the arsenic-TL interaction effect on skin lesion risk based on a prior study observing that risk factors of skin lesion (i.e. metabolism profile) can vary by the level of arsenic exposure (Jansen et al., 2015) . Age and sex were chosen for effect modification analyses based on prior studies that observed males and older participants were more susceptible to arsenic effects on skin lesions , suggesting that some risk factors of skin lesion vary by age and sex. A summary of all associations and potential interaction being investigated is depicted in Supplementary Fig. 3 .
All analyses were conducted using Stata (version 14, StataCorp, College Station, TX).
Results
Subject characteristics
The baseline characteristics, arsenic exposure, and TL measures of the age-and sex-matched skin lesion cases (n = 466) and controls (n = 464) used for the nested case-control study are shown in Table 1 along with characteristics of the random subcohort (n = 1469) used for the arsenic-TL association analysis. Among the subjects in the random subcohort, 40 had prevalent skin lesions at baseline and 74 developed skin lesions during the study follow-up. Baseline statistics of the subcohort subjects are summarized in Supplementary Table 3 and displayed as histograms in Supplementary Fig. 4 . TL was inversely associated with age within the random subcohort (P = 1.1 × 10 -14 )
( Supplementary Fig. 5 ), the case group (P = 0.002), and the control group (P = 0.02).
Association between arsenic and TL
Arsenic exposure was not associated with TL in the random subcohort for either minimally-adjusted or fully-adjusted models assessing water arsenic (beta = −0.002; 95% CI − 0.022-0.019; P = 0.86; comparing the highest quartile to the lowest), urinary arsenic (beta = 0.007; 95% CI − 0.013-0.027; P = 0.49), and daily dose arsenic (beta= 0.010; 95% CI − 0.010-0.029; P = 0.32) ( Table 2) . Estimates were also null using log-transformed continuous measures of arsenic exposure (Table 2) , comparing TL in subjects with the top decile of arsenic exposure to the bottom decile, and in subjects with the top decile of arsenic exposure to all other subjects with lower exposure for all three arsenic measures (not shown). SNP rs9527, a variant previously shown to be associated with arsenic metabolism efficiency, was also not associated with TL (beta = 0.002; 95% CI − 0.007, 0.010; P = 0.70).
Association between arsenic and skin lesion
In the nested case-control study, the odds ratios for incident skin lesions comparing the second, third, and fourth quartiles with the lowest quartile of well water arsenic exposure were OR = 1.23; 95% CI 0.75-2.03; OR = 2.16; 95% CI 1.38-3.39; and OR = 4.88; 95% CI 3.07-7.77, respectively. This is consistent with the arsenic-skin lesion association described previously in a prospective study of the entire cohort of 10,182 subjects (Argos et al., 2011) .
Association between TL and skin lesion
Short TL was associated with increased skin lesion incidence in a dose-dependent manner with similar estimates for a minimally-adjusted model (OR = 2.60; 95% CI 1.61-4.19; P = 1.5 × 10 −5 comparing the shortest TL quartile to the longest), and a fully-adjusted model with water arsenic exposure included as a covariate (OR = 2.86; 95% CI 1.72-4.75; P = 2.2 × 10
−5
). Similar estimates were also observed when adjusting for urinary arsenic or daily dose of arsenic, and when analyses were repeated using a continuous measure of TL (Table 3) . Stratified analyses by skin lesion subtype (melanosis, leucomelanosis, or keratosis) showed similar estimates (Supplementary Table 4) . Furthermore, there was suggestive evidence that subjects with shorter TL were more likely to be diagnosed at an earlier follow-up, although estimates were unstable due to small sample sizes (results not shown).
Interaction analyses
We observed suggestive evidence that TL showed a positive association with arsenic (P = 0.04) in younger subjects (≤ 45 years old) and negative association with arsenic (P = 0.04) among older subjects (> 45), although estimates were unstable due to small samples sizes (results not shown). No effect modification by sex was observed in the association between arsenic exposure and TL (results not shown). Tests for additive interaction suggest the presence of effect modification by TL on the arsenic-skin lesion association for the three arsenic exposures (P interaction = 0.046-0.059), but this was not observed for tests for multiplicative interaction (P interaction = 0.093-0.41). Odds ratios of skin lesion risk according to strata of arsenic exposure and TL quartiles compared to a common reference group of low arsenic exposure and long TL are presented in Table 4 . The additive interaction tests corresponded to interaction estimates of RERI = 0.52, 95% CI: − 0.02, 1.05 for water arsenic, RERI = 0.26, 95% CI: 0.00, 0.51 for creatinine-adjusted urinary arsenic, and RERI = 0.33, 95% CI: 0.00, 0.65 for daily arsenic exposure. On the additive scale, the interpretation is that with every category increase in arsenic exposure and quartile decrease in TL, the odds ratio of skin lesion ranges from 0.26 to 0.52 more than if there were no interaction for the three arsenic exposures. A different presentation of interaction effects showing the odds ratios of skin lesion due to increasing arsenic exposure, stratified by TL quartile (with four reference groups), are also presented in Supplementary Table 5 . In analyses stratified by sex, the association between TL and skin lesion risk appeared substantially larger for women than men, i.e. short TL was associated with larger increased risk in skin lesions among female subjects. However, this analysis was not well-powered, and the P value for interaction term was not significant (P interaction = 0.48; Supplementary Table 6 ). No differences by age were observed in the stratified analyses (results not shown).
Discussion
In this cohort-based study of Bangladeshi adult men and women, we found no association between baseline arsenic exposure and baseline TL. However, we observed an association between short baseline TL and increased risk of subsequent arsenical skin lesions.
Our observation of a lack of association between arsenic exposure and TL was additionally supported by a lack of association between a genetic variant associated with arsenic metabolism efficiency (and therefore effective dose of arsenic) and TL. The observed lack of association between arsenic exposure and TL in this study differed from four prior epidemiologic studies, three of which suggested a positive association between arsenic exposure and TL (Gao et al., 2015; Li et al., 2012; Ameer et al., 2016) , and one which suggested an inverse association (Borghini et al., 2016) . However, it is important to note that all four prior studies were limited by small sample sizes (n < 400) and generally reported modest associations. A fifth study observed a positive association between high arsenic exposure and longer TL among subjects with skin lesions (Chatterjee et al., 2015) , although this association is potentially susceptible to collider-stratification bias due to stratifying on skin lesion status, a potential common outcome of both arsenic exposure and TL (Cole et al., 2010) . Furthermore, studies by both Chatterjee et al. and Li et al. were limited to comparing TL in high arsenic exposed subjects from one region to low arsenic exposed subjects from a different region -a design susceptible to potential biases due to confounding by other local factors. Another study by Fillman et al. was not susceptible to this potential issue as all subjects were from the same district, and notably, the positive association observed between arsenic exposure and TL was not statistically significant (P trend = 0.11) (Fillman et al., 2016) . The assessment of arsenic exposure among prior studies were generally comparable to the current study with measurements of urinary arsenic having medians of 230 µg/L (Li et al., 2012) , 80 µg/L (Ameer et al., 2016) , and 196 µg/L (Ameer et al., 2016) , and a creatinine adjusted urinary arsenic median of 196.0 ± 301.1 µg/g (mean ± standard deviation) (Fillman et al., 2016) . The exception was one study assessing TL only in subjects with high water arsenic exposure, 153 ± 65.5 µg/L (Chatterjee et al., 2015) .
Previous in vitro studies of arsenic exposure on cell cultures suggest a bimodal effect of arsenic on TL in which low doses either maintain or lengthen TL, while high doses shorten TL (Ferrario et al., 2009; Zhang et al., 2003; Liu et al., 2003) . However, it is unclear if the range of arsenic concentrations tested in vitro in these studies corresponds to the same range of exposures experienced by human hematopoietic cells in vivo via arsenic-contaminated drinking water. Furthermore, in vitro P trend = 2.5 × 10
−5
a Reduced sample sizes reflect missing covariate data. b Odds ratio for each unit decrease in standardized telomere length. c Adjusting for age, sex, and laboratory batch variables. d Water arsenic exposure modeled as four levels with the first two cut points defined according to the WHO's guideline for arsenic in drinking water (≤ 10 µg/L) and Bangladesh's national standard for arsenic in drinking water (≤ 50 µg/L), and the third cut point selected based on the upper third and fourth quartiles of water arsenic exposure, and additionally adjusting for BMI, education, smoking status, TV ownership, and land ownership. e Arsenic measures coded as quartiles, and additionally adjusting for BMI, education, smoking status, TV ownership, and land ownership.
C. Zhang et al. Environmental Research 164 (2018) 346-355 Multiplicative P interaction term generated by multiplying well water arsenic exposure category (i.e. 1-4) by telomere length quartiles.
c Additive P value for the relative excess risk to due interaction (RERI).
C. Zhang et al. Environmental Research 164 (2018) 346-355 studies performed over hours, days, or even weeks may not be suitable for extrapolating effects corresponding to years of chronic arsenic exposure in humans. The observation that TL is positively associated with arsenic exposure among younger subjects (< 45 years old) and negatively associated in older subjects (≥ 45 years old) suggests that the window or length of exposure may determine the nature of the arsenic-TL association. Furthermore, the opposing directions of associations of the age strata may have masked each other, resulting in the null association observed in the subcohort analysis among all ages. Differential response to arsenic exposure by age was previously observed for skin lesion incidence, possibly due to biologic factors associated with aging, or a longer exposure time (Ahsan et al., 2006) . Children and adolescents have been observed to more efficiently methylate arsenic than adults Löveborn et al., 2016) , which suggests that they may experience a lower "effective" arsenic dose compared to adults. However, the current analysis was underpowered for estimating this interaction, and additional studies of larger sample sizes are necessary to further elucidate any effect modification of age on the arsenic-TL association.
Our observation of increased skin lesion risk associated with short TL stands in contrast to the only other epidemiologic study on TL and arsenical skin lesions (Chatterjee et al., 2015) , which found increased skin lesion risk for individuals with longer TL. However, unlike our prospective study design, these findings were based on a cross-sectional study design and potentially susceptible to issues of reverse causality.
There is no prior literature regarding the effect modification we observed, i.e. a stronger association between arsenic exposure and skin lesion risk in subjects with shorter TL. However, previous studies have described effect modification on the additive scale of arsenic-induced skin lesions by smoking and fertilizer use, suggesting that some risk factors of skin lesions interact with arsenic exposure to further increase skin lesion risk Melkonian et al., 2011) . Furthermore, a previous in vitro study on apoptosis in human cell-lines showed that treatment with a telomerase inhibitor (thereby disrupting TL maintenance) enhances arsenic-induced apoptosis. Although the exact biological mechanism underlying this observation remains unclear, this study suggests a potential synergism between effects of arsenic exposure and an altered telomere state on the cell cycle. Additional investigations to replicate and elucidate this observed differential arsenic susceptibility are necessary.
Generalizability of our findings to other populations likely depend on the arsenic exposure levels and the distribution of TL in those populations. Given the interaction effect between arsenic and TL on skin lesion risk observed in this study, different magnitudes of association between TL and skin lesion risk may be observed in other populations exposed to higher or lower levels of arsenic. Differences in average leukocyte TL between populations (e.g. shorter TL in individuals of European ancestry compared to individuals of African ancestry (Sanders and Newman, 2013) ) may also contribute to differences from the described associations in other populations, although no study to date has assessed leukocyte TL of Bangladeshi individuals relative to other race/ethnicities. This study has several key strengths. For estimating the arsenic-TL association, we used a randomly-selected subset from the HEALS population-based cohort, which is representative of the local population, thus reducing the risk of selection bias. Both the arsenic-TL and the TLskin lesion analyses had much larger sample sizes than prior studies, providing superior statistical power. Our analyses involved comprehensive adjustment of potential confounders as covariates. Subjects in this study have a wide range of arsenic exposure levels with multiple types of arsenic exposure measurements collected. Our study of TL and skin lesion risk is prospective in design with controls selected from the same cohort as the cases, and TL measured prior to skin lesion ascertainment, thus reducing potential issues of reverse causality and selection bias.
Prior research indicates high correlation between TL measured in leukocyte and skin (r = 0.83) (Daniali et al., 2013) . Thus, TL measures obtained from peripheral blood cells are likely to be proxies for TL in skin, suggesting a biological mechanism underlying the association we observe between TL and skin lesion risk. However, not all tissues in the body accumulate arsenic equally, with studies in both human and mice models showing higher accumulation of arsenic in skin than in blood (due in part to arsenic's affinity to keratin in skin) (Hughes et al., 2003; Hughes et al., 2009; Saha et al., 1999) . Thus, it is possible that chronic arsenic exposure affects TL in skin cells (or other tissues), but not the blood-based TL measures analyzed in this study. Future analyses examining arsenic levels and TL from biopsied skin samples may be necessary to clarify this issue.
Due to limitations in resources and DNA availability, our analyses were restricted to a random subset of 1469 rather than the full HEALS cohort and to 516 cases in the nest case-control study rather than all 896 skin lesion incident cases. Arsenic exposure levels were somewhat higher for the skin lesion cases that were measured for TL compared to skin lesion cases that were excluded (Supplementary Table 1) ; such variability could potentially bias the estimates of the association between TL and skin lesion, although we believe this is unlikely due to the lack of association observed between arsenic and TL, i.e. arsenic is unlikely to be a confounder. Another limitation of this study is the use of qPCR to measure TL, a method which exhibits greater variability in measurements than the "gold standard" Southern blot method (Aviv et al., 2011) . Such non-differential measurement error may result in association estimates biased towards the null. Another potential limitation of the arsenic-TL association analysis is that arsenic measures may not represent cumulative lifetime exposure. However, participants selected into HEALS were required to be residents of the study area for at least 5 years and primarily drinking water from one of the study wells for at least 3 years (Ahsan et al., 2005) , so the baseline exposure estimates are likely to represent stable long-term arsenic exposure through drinking water. Prior studies have shown that well-switching is not frequent when arsenic-status of wells are not known Schoenfeld, 2005) . For this reason, well-switching before baseline is not a likely confounder as HEALS participants were not aware of the arsenic statuses of wells, which were measured and made known just after baseline. Nevertheless, future studies of the impact of different exposure windows on the association between arsenic and TL are worthwhile, particularly in children and/or adolescents who may be more susceptible to chronic arsenic exposure. Furthermore, longitudinal studies with repeated arsenic and TL measures would allow for more rigorous estimation of the association between lifetime arsenic exposure and TL, as well as clarify when best to measure TL as a predictive biomarker for subsequent health outcomes.
Conclusions
Our findings suggest a lack of association between arsenic exposure and blood TL in adults. However, our observation that short TL is associated with risk for subsequent arsenical skin lesions has potential implications for elucidating the biological mechanisms linking arsenic exposure to skin lesions, predicting individual susceptibility to arsenicinduced skin lesions, as well as future investigations of other arsenicrelated health conditions.
